I-SABR-SELECT: A Radiomics-Based Model for Personalized Immunotherapy for Early-Stage NonSmall Cell Lung Cancer

被引：0

作者：

Saad, M. B. ^{[1
]}

Showkatian, E. ^{[1
]}

Al-Tashi, Q. ^{[1
]}

Aminu, M. ^{[1
]}

Xinyan, X. ^{[1
]}

Mohamed, M. Qayati ^{[1
]}

Salehjahromi, M. ^{[1
]}

Sujit, S. J. ^{[1
]}

Lin, S. H. ^{[2
]}

Liao, Z. ^{[2
]}

Gandhi, S. ^{[2
]}

Qian, D. ^{[2
]}

Jaffray, D. A. ^{[1
,3
]}

Chung, C. ^{[2
,3
]}

Vokes, N. ^{[4
]}

Zhang, J. ^{[4
]}

Heymach, J. V. ^{[4
]}

Wu, J. ^{[1
,3
,4
]}

Chang, J. Y. ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Inst Data Sci Oncol, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

SABR; Immunotherapy; Radiomics;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA13.05

引用

页码：S40 / S40

页数：1

共 50 条

[1] CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer
Wang, Jiexiao
Wang, Jialiang
Huang, Xiang
Zhou, Yanfei
Qi, Jian
Sun, Xiaojun
Nie, Jinfu
Hu, Zongtao
Wang, Shujie
Hong, Bo
Wang, Hongzhi
BMC MEDICAL IMAGING, 2024, 24 (01)
[2] CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer
Jiexiao Wang
Jialiang Wang
Xiang Huang
Yanfei Zhou
Jian Qi
Xiaojun Sun
Jinfu Nie
Zongtao Hu
Shujie Wang
Bo Hong
Hongzhi Wang
BMC Medical Imaging, 24
[3] Moving Immunotherapy Into Early-Stage Lung Cancer
Linehan, Anna
Forde, Patrick M.
CANCER JOURNAL, 2020, 26 (06): : 543 - 547
[4] Immunotherapy for early-stage non-small cell lung cancer: A system review
Gao, Jingyi
Zhang, Chao
Wei, Zhigang
Ye, Xin
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (04) : 849 - 865
[5] Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
Shukla, Nikhil
Hanna, Nasser
LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 51 - 60
[6] Nivolumab After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Randomized I-SABR Trial
Chang, J. Y.
Lin, S. H.
Dong, W.
Liao, Z.
Gandhi, S.
Chun, S. G.
Gay, C. M.
Zhang, J.
Fossella, F. V.
Blumenschein, G. R.
Cascone, T.
Le, X.
Pozadzides, J. V.
Tsao, A.
Mehmet, A.
Welsh, J. W.
Verma, V.
Wistuba, I. I.
Lee, J.
Heymach, J.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S71 - S71
[7] The beginning of the perioperative immunotherapy era in early-stage non-small cell lung cancer
Riano, Ivy
Dragnev, Konstantin H.
Phillips, Joseph D.
TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (11) : 2359 - 2365
[8] A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
Yang, Hong
Wang, Lin
Shao, Guoliang
Dong, Baiqiang
Wang, Fang
Wei, Yuguo
Li, Pu
Chen, Haiyan
Chen, Wujie
Zheng, Yao
He, Yiwei
Zhao, Yankun
Du, Xianghui
Sun, Xiaojiang
Wang, Zhun
Wang, Yuezhen
Zhou, Xia
Lai, Xiaojing
Feng, Wei
Shen, Liming
Qiu, Guoqing
Ji, Yongling
Chen, Jianxiang
Jiang, Youhua
Liu, Jinshi
Zeng, Jian
Wang, Changchun
Zhao, Qiang
Yang, Xun
Hu, Xiao
Ma, Honglian
Chen, Qixun
Chen, Ming
Jiang, Haitao
Xu, Yujin
FRONTIERS IN ONCOLOGY, 2022, 12
[9] Quality of life after VATS lung resection and SABR for early-stage non-small cell lung cancer: A longitudinal study
Pompili, Cecilia
Rogers, Zoe
Absolom, Kate
Holch, Patricia
Clayton, Beverly
Callister, Matthew
Robson, Johnathan
Brunelli, Alessandro
Franks, Kevin
Velikova, Galina
LUNG CANCER, 2021, 162 : 71 - 78
[10] Review of the use of radiomics to assess the risk of recurrence in early-stage non-small cell lung cancer
Libling, William Adam
Korn, Ronald
Weiss, Glen J.
TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (07) : 1575 - 1589

← 1 2 3 4 5 →